OSR Health OSRH
OTC OSRH
$0.24 +0.01 (+4.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

OSR Health (OSRH) Gains from Sales and Divestitures (2024)

Updated

OSR Health (OSRH) recorded Gains from Sales and Divestitures of $1,318 in Q4 2024.

Analysis

OSR Health (OSRH) Gains from Sales and Divestitures (2024) Analysis & Trends

For FY2024, OSR Health reported Gains from Sales and Divestitures of -$2,159.

  • Per Business Quant, the preceding three quarters came in at -$2,245 (Q3 2024), -$606.00 (Q2 2024) and -$626.00 (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 OSR Health 7.89 Mn 20.86 Mn 86,605.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1,318.00
Sep 30, 2024 -2,245.00
Jun 30, 2024 -606.00
Mar 31, 2024 -626.00
API Access

OSR Health Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=OSRH&period=max&api_key=YOUR_API_KEY